Polymorphisms and defects in FAT/CD36 transcription and translation alter normal lipid metabolism, producing obesity, metabolic syndrome, atherosclerosis, arterial hypertension, diabetes, cardiomyopathy, Alzheimer’s disease, and multiple sclerosis. Here, CD36 is linked to multiple sclerosis.